Alfonso Allyson R, Ramly Elie P, Kantar Rami S, Rifkin William J, Diaz-Siso J Rodrigo, Gelb Bruce E, Yeh Joseph S, Espina Mark F, Jain Sudheer K, Piper Greta L, Rodriguez Eduardo D
Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, N.Y.
Transplant Institute, NYU Langone Health, New York, N.Y.
Plast Reconstr Surg Glob Open. 2020 Aug 17;8(8):e2955. doi: 10.1097/GOX.0000000000002955. eCollection 2020 Aug.
Anesthetic considerations are integral to the success of facial transplantation (FT), yet limited evidence exists to guide quality improvement. This study presents an institutional anesthesia protocol, defines reported anesthetic considerations, and provides a comprehensive update to inform future directions of the field.
An institutional "FT Anesthesia Protocol" was developed and applied to 2 face transplants. A systematic review of 3 databases captured FTs in the peer-reviewed literature up to February 2020. Two reviewers independently screened titles and abstracts to include all clinical articles with FT recipient and/or donor-specific preoperative, intraoperative, and relevant postoperative anesthetic variables. Data charting guided a narrative synthesis, and quantitative synthesis reported variables as median (range).
Our institutional experience emphasizes the importance of on-site rehearsals, anticipation of patient-specific anesthetic and resuscitative requirements, and long-term pain management. Systematic search identified 1092 unique records, and 129 met inclusion criteria. Reports of 37 FTs in the literature informed the following anesthetic axes: donor pre- and intraoperative management during facial allograft procurement, recipient perioperative care, immunotherapy, antimicrobial prophylaxis, and pain management. Quantitative synthesis of 30 articles showed a median operative time of 18 hours (range, 9-28) and fluid replacement with 13 L (5-18) of crystalloids, 13 units (0-66) of packed red blood cells, 10 units (0-63) of fresh frozen plasma, and 1 unit (0-9) of platelets.
Anesthetic considerations in FT span the continuum of care. Future efforts should guide standard reporting to establish evidence-based strategies that promote quality improvement and patient safety.
麻醉考量对于面部移植(FT)的成功至关重要,但指导质量改进的证据有限。本研究提出了一项机构麻醉方案,定义了已报道的麻醉考量,并提供了全面更新以指导该领域的未来方向。
制定了一项机构“FT麻醉方案”并应用于2例面部移植手术。对3个数据库进行系统综述,检索截至2020年2月同行评审文献中的面部移植案例。两名评审员独立筛选标题和摘要,纳入所有包含面部移植受者和/或供者特定术前、术中和相关术后麻醉变量的临床文章。数据图表指导了叙述性综合分析,定量综合分析将变量报告为中位数(范围)。
我们的机构经验强调了现场预演、预期患者特定的麻醉和复苏需求以及长期疼痛管理的重要性。系统检索识别出1092条独特记录,其中129条符合纳入标准。文献中37例面部移植的报告为以下麻醉要点提供了信息:面部同种异体移植物获取期间供者的术前和术中管理、受者围手术期护理、免疫治疗、抗菌预防和疼痛管理。对30篇文章的定量综合分析显示,中位手术时间为18小时(范围9 - 28小时),晶体液补液量为13升(5 - 18升),浓缩红细胞13单位(0 - 66单位),新鲜冰冻血浆10单位(0 - 63单位),血小板1单位(0 - 9单位)。
面部移植中的麻醉考量贯穿整个护理过程。未来的努力应指导标准化报告,以建立促进质量改进和患者安全的循证策略。